Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course.
Jonathan MuriValentina CecchinatoAndrea CavalliAkanksha A ShanbhagMilos MatkovicMaira BiggiogeroPier Andrea MaidaChiara ToscanoElaheh GhovehoudGabriela Danelon-SargentiTao GongPietro PiffarettiFilippo BianchiniVirginia CrivelliLucie PodešvováMattia PedottiDavid JarrossayJacopo SgrignaniSylvia ThelenMario UhrEnos BernasconiAndri RauchAntonio ManzoAdrian CiureaMarco Bruno Luigi RocchiLuca VaraniBernhard MoserMarcus ThelenChristian GarzoniAlessandra Franzetti-PellandaMariagrazia UguccioniDavide F RobbianiPublished in: bioRxiv : the preprint server for biology (2022)
Naturally arising anti-chemokine antibodies associate with favorable COVID-19 and are predictive of lack of long COVID.